Drug Giant AstraZeneca Launches Evinova to Quicken Clinical Trials
Evinova aims to use AI to design studies, automate cost calculations, and determine feasibility for drug testing.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
Why this matters
This cryptocurrency story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on DecryptRelated market context
Sui’s Hashi Launches With $500M to Turn Bitcoin Into Productive DeFi Collateral Markets
Key Takeaways: With more than $500 million in locked-in tokens, Hashi will launch its phased mainnet launch. The protocol enables...
Bitcoin Price Briefly Reclaims $81,000 as Liquidations Top $1 Billion
Bitcoin price fell for a fourth consecutive day, briefly slipping below $81,000 before rebounding, as the total crypto market cap...
Sui’s Hashi Bitcoin Finance Network Launches With More Than $500 Million Committed
TL;DR: Hashi, Sui’s native Bitcoin finance infrastructure, will begin a phased mainnet rollout later this month with more than $50...
Chainlink Launches One-Click Cross-Chain Vault Deposits Across 80+ Blockchains
TL;DR: Chainlink has launched CCIP Vault Adapters, allowing DeFi vaults on one network to accept deposits from users across more t...
Securitize launches tokenized Apple, Nvidia, and Tesla stocks on Solana
Tokenizing stocks on Solana could democratize access to equities, enhance liquidity, and pave the way for 24/7 trading, reshaping...
Securitize launches 1:1-backed tokenized stocks, starting with Apple, Nvidia, Strategy and more
Securitize launches tokenized US stocks on Solana, backed 1:1 by real shares with dividends and USDC settlement.